Liliana Soroceanu

Liliana Soroceanu, MD PhD, currently serves as the Translational Medicine-Biomarker Lead and Senior Principal Scientist at ORIC Pharmaceuticals Inc., focusing on clinical biomarker development for precision oncology targets since November 2023. Previously, Liliana worked as the Director of Translational Medicine at Kinnate Biopharma Inc. from January to October 2023 and as a Senior Scientist at CPMC Research Institute from October 2015 to January 2023, where Liliana led a multi-disciplinary team in translational oncology, emphasizing target discovery and combinatorial therapies. Earlier experience includes roles as a Scientist at CPMC Research Institute (2007-2015), investigating the role of cytomegalovirus in cancer, and as a Postdoctoral Research Fellow at Genentech (2002-2007), contributing to the molecular classification of glioblastoma. Liliana holds a PhD in Neurobiology from the University of Alabama at Birmingham and an MD from Grigore T. Popa University of Medicine and Pharmacy Iași.